Lv11
100 积分 2021-06-28 加入
Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study
13小时前
已完结
Bioequivalence study of voriconazole for intravenous infusion in healthy Chinese subjects under fasting conditions
2天前
求助中
Global patterns of leukemia by subtype, age, and sex in 185 countries in 2022
1个月前
已完结
Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study
1个月前
已完结
Etoposide addition and brentuximab vedotin consolidation in first-line treatment of CD30-positive peripheral T-cell lymphoma: can we improve BV–CHP?
1个月前
已完结
Adult Acute Lymphoblastic Leukemia: 2025 Update on Diagnosis, Therapy, and Monitoring
1个月前
已完结
Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study
1个月前
已完结
Current landscape of CD3 bispecific antibodies in hematologic malignancies
2个月前
已完结
Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial
2个月前
已完结
Human γδ T cells in diverse tissues exhibit site-specific maturation dynamics across the life span
3个月前
已完结
皖公网安备34019202002308
